Elevance Health said it held its Annual Meeting of Shareholders on May 13, 2026, with 194,441,339 shares of common stock represented, constituting a quorum.

1. 01

   Elevance Health said it held its Annual Meeting of Shareholders on May 13, 2026, with 194,441,339 shares of common stock represented, constituting a quorum.

2. 02

   The company said 3 director nominees—Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable—were elected to serve 3-year terms expiring at the Company's annual meeting of shareholders in 2029. It said Boudreaux received 177,978,713 votes for and 1,714,229 votes against.

3. 03

   Elevance Health said the advisory vote on the compensation of the Company's named executive officers was approved with 172,363,616 votes for and 7,240,619 votes against. It said the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified with 175,183,332 votes for and 19,141,697 votes against.

4. 04

   The company said a shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups was not approved, with 15,587,160 votes for and 162,924,290 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.